
Medicine and Health
A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug
Q. Liu, Y. Lu, et al.
Discover VHH60, a groundbreaking neutralizing nanobody that competes with human ACE2 to inhibit SARS-CoV-2 infection. Developed by an expert team, this nanobody shows superior protective capabilities against both ancestral and variant strains, showcasing a rapid approach to therapeutic innovation.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.